Article
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.
EBioMedicine - 1 Nov 2015
Song Taeksun, Lee Myungsun, Jeon Han-Seung, Park Yumi, Dodd Lori E, Dartois Véronique, Follman Dean, Wang Jing, Cai Ying, Goldfeder Lisa C, Olivier Kenneth N, Xie Yingda, Via Laura E, Cho Sang Nae, Barry Clifton E, Chen Ray Y
Abstract excerpt
Long-term linezolid use is limited by mitochondrial toxicity-associated adverse events (AEs). Within a prospective, randomized controlled trial of linezolid to treat chronic extensively drug-resistant tuberculosis, we serially monitored the translational competence of mitochondria isolated from peripheral blood of participants by determining the cytochrome c oxidase/citrate synthase activity ratio. We compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
